基于 DNA 超分子水凝胶的保护性 NK 细胞储库用于增强三阴性乳腺癌治疗
Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tumor cell-released autophagosome (TRAP) programs inflammatory CAFs to drive the immune-excluded TIME through C3a.
Tumor cell-released autophagosome (TRAP) programs inflammatory CAFs to drive the immune-excluded TIME through C3a.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
免疫排斥型肿瘤免疫微环境(TIME)限制了对ICIs的应答。癌相关成纤维细胞是最丰富的基质细胞群体,也是免疫抑制的关键调控者;然而,编程致病性CAF状态的上游信号以及免疫排斥型TIME的机制仍不明确。
在此,我们通过结合单细胞RNA测序和功能验证,报道肿瘤细胞释放的自噬体(TRAP)编程炎症性CAFs(iCAFs),并通过HSP70-TLR4-MyD88-ERK/p38通路触发组织蛋白酶L依赖的细胞内C3切割为C3a。iCAF来源的C3a作用于TAMs上的C3a,促进TAM在富含iCAF的基质中积聚,限制TIL向肿瘤巢的转运,并强化免疫排斥型TIME。破坏TRAP-iCAF-C3a/C3aR轴可重塑免疫排斥型TIME并使肿瘤对抗PD-L1治疗敏感。在临床队列中,血浆TRAP和C3a水平随疾病分期增加,且二者联合提高了乳腺癌患者与对照者的区分能力(AUC = 0.96)。这些数据定义了一个促进免疫排斥的TRAP驱动的基质-免疫回路,并提示C3a-C3aR轴是增强ICI疗效的潜在靶点。
The immune-excluded tumor immune microenvironment (TIME) limits responses to ICIs. Cancer-associated fibroblasts are the most abundant stromal population and key regulators of immune suppression; however, the upstream cues that program pathogenic CAF states and the mechanisms of the immune-excluded TIME remain poorly defined.
Here, by combining single-cell RNA sequencing and functional validation, we report that tumor cell-released autophagosome (TRAP) programs inflammatory CAFs (iCAFs) and triggers cathepsin L-dependent intracellular cleavage of C3 into C3a via the HSP70-TLR4-MyD88-ERK/p38 pathway. iCAF-derived C3a affects C3a on TAMs, promotes TAM accumulation in the iCAF-rich stroma, limits TIL trafficking into tumor nests, and reinforces an immune-excluded TIME.
Disrupting the TRAP-iCAF-C3a/C3aR axis remodels the immune-excluded TIME and sensitizes tumors to anti-PD-L1 therapy. In clinical cohorts, plasma TRAP and C3a levels increased with disease stage, and their combination improved the discrimination of patients with breast cancer from controls (AUC = 0. 96). These data define a TRAP-driven stromal-immune circuit that promotes immune exclusion and suggest that the C3a-C3aR axis is a potential target for enhancing ICI efficacy.
MEMBER ACCOUNT
登录成功会直接打开下一页。